Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA
Target Price
The average target price of FAGR.BR is 25 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell